Lv11
52 积分 2022-02-24 加入
Quantitative serum HBsAg and HBeAg are strong predictors of sustained HBeAg seroconversion to pegylated interferon alfa-2b in HBeAg-positive patients
12天前
已完结
Monitoring of antiviral therapy with quantitative evaluation of HBeAg: A comparison with HBV DNA testing
12天前
已关闭
VIDAS3® TB-IGRA assay: evaluation of performance characteristics in a predominantly low risk, low incidence population
27天前
已完结
Performance evaluation of the MAGLUMI Hepatitis B virus surface antigen chemiluminescence immunoassay
1个月前
已完结
Real‐world study on HBsAg loss of combination therapy in HBeAg‐negative chronic hepatitis B patients
1个月前
已完结
Roadmap for Patients Receiving Oral Therapy for Chronic Hepatitis B and Quantification of HBV DNA、HBeAg and HBsAg level
1个月前
已完结
The signification and method of HBeAg gray zone setting and its cut-off verification in chemiluminescent assay
1个月前
已完结
Treatment and Prevention of Acute Hepatitis B Virus
2个月前
已完结
Low level of HBcrAg is beneficial to functional cure obtained with pegylated interferon therapy in inactive HBsAg carriers
2个月前
已完结
皖公网安备34019202002308
